Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2017

Sep 15, 2017

30561_dirs_2017-09-14_86821cf2-aed4-4c7b-87ce-928205489ba3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-09-12

Reporting Person: Senner Christopher J. (EVP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-09-12 Common Stock M 100000 $3.66 Acquired 202759 Direct
2017-09-12 Common Stock S 100000 $26.79 Disposed 102759 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-12 Option (right to buy) $3.66 M 100000 Disposed 2022-07-14 Common Stock (100000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2039 Indirect

Footnotes

F1: Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,361 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan on April 28, 2017.

F2: Represents 2,039 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 12, 2017.

F3: The option, representing the right to purchase a total of 350,000 shares of Exelixis, Inc. common stock, was exercisable as to 182,291 shares on the Transaction Date. Th remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of July 15, 2015 grant date.